Vanguard Group Inc. Sells 5,389 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Vanguard Group Inc. lessened its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 1.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 306,235 shares of the company’s stock after selling 5,389 shares during the quarter. Vanguard Group Inc. owned about 3.30% of Semler Scientific worth $16,537,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in SMLR. Jones Financial Companies Lllp bought a new position in shares of Semler Scientific during the fourth quarter worth $34,000. Larson Financial Group LLC bought a new stake in shares of Semler Scientific in the fourth quarter worth about $38,000. IFP Advisors Inc purchased a new stake in shares of Semler Scientific in the fourth quarter worth about $54,000. Global Retirement Partners LLC boosted its position in shares of Semler Scientific by 62.5% during the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock valued at $70,000 after acquiring an additional 500 shares during the last quarter. Finally, Douglass Winthrop Advisors LLC bought a new stake in Semler Scientific in the fourth quarter worth $232,000. 49.37% of the stock is owned by hedge funds and other institutional investors.

Semler Scientific Price Performance

Semler Scientific stock opened at $31.00 on Thursday. The firm has a market capitalization of $297.51 million, a P/E ratio of 6.31 and a beta of 1.29. The company’s 50-day moving average is $39.31 and its 200 day moving average is $45.52. Semler Scientific, Inc. has a 1-year low of $20.88 and a 1-year high of $81.56.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping the consensus estimate of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Analyst Ratings Changes

Separately, Lake Street Capital boosted their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, January 24th.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.